Califf Sits Down For Fireside Chat; Looks Back And Ahead
Executive Summary
Robert Califf marked his one-year anniversary as the commissioner of the US Food and Drug Administration by discussing the first year of his second term as the agency’s chief executive and his vision for the future.
You may also be interested in...
FDA Going Down ‘Pathway’ Of A Rule On LDTs, Califf Says
During a webinar hosted by the Alliance for a Stronger FDA, commissioner Robert Califf said the agency was on the path to using its rulemaking authority to regulate laboratory-developed tests.
FDA Prepares To Regulate LDTs, One Way Or The Other
US FDA officials have said multiple times that they plan to move to regulate lab-developed tests, with or without Congressional action. And this week, the agency made a formal announcement of those intentions via the Unified Agenda.
'All Options On The Table,' Says Hillebrenner On Diagnostics Reform
During a recent webinar hosted by the Alliance for a Stronger FDA, Elizabeth Hillebrenner, associate director for scientific and regulatory programs at the agency’s device center, vowed to keep fighting for diagnostic reform despite Congress failing to pass the VALID Act last year.